SCHEMBL8873607

SCHEMBL8873607

C=CCOC(=O)C1(C)C=CC(=O)CC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.34
TSHR P16473 3/20 0.33
TP53 P04637 2/20 0.33
ALDH1A1 P00352 3/20 0.32
GAA P10253 2/20 0.32
RECQL P46063 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
POLB P06746 1/20 0.32
NPSR1 Q6W5P4 1/20 0.31
CYP19A1 P11511 2/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
HSD17B10 Q99714 2/20 0.31
KDM4E B2RXH2 1/20 0.31
HPGD P15428 1/20 0.31
ALOX5 P09917 1/20 0.31
RXRA P19793 1/20 0.31
RXRB P28702 1/20 0.31
RXRG P48443 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7196359 0.70 CYP3A4 (0.42) CYP3A4TSHRTP53ALDH1A1GAA
SCHEMBL2167134 0.69 CYP3A4 (0.41) CYP3A4TSHRTP53ALDH1A1GAA
SCHEMBL23687221 0.69 ALDH1A1 (0.34) CYP3A4TSHRTP53ALDH1A1GAA
SCHEMBL18101499 0.68 CYP3A4 (0.38) CYP3A4TSHRTP53ALDH1A1GAA
SCHEMBL16315457 0.68 CYP19A1 (0.34) CYP19A1ALOX5
SCHEMBL14498565 0.68 ALDH1A1 (0.33) CYP3A4TSHRTP53ALDH1A1GAA
SCHEMBL18101500 0.67 ALDH1A1 (0.35) CYP3A4TSHRTP53ALDH1A1GAA
SCHEMBL18101498 0.67 ALDH1A1 (0.33) CYP3A4TSHRTP53ALDH1A1GAA
SCHEMBL3784428 0.66 CYP3A4 (0.39) CYP3A4TSHRTP53ALDH1A1GAA
SCHEMBL7175708 0.65 CYP3A4 (0.38) CYP3A4TSHRTP53ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5624950-A USEFUL IN TREATMENT OF ANALGESIA, INFLAMMATION, ASTHMA, ALLERGIES, CENTRAL NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS, IMMUNE SYSTEM DISORDERS, ANTISPASMODIC AGENTS, ANTIEMETIC AGENTS RHONE-POULENC RORER S.A. (FR) 1997-04-29 US disclosed